Using Cardiac AngioMR to Diagnose Heart and Vascular Issues in Adults with Turner Syndrome
Role of Cardiac Magnetic Resonance Angiography (1.5-T) in the Diagnosis of Cardiac and Thoraco-abdominal Vascular Tree Anomalies in Adult Patients with Turner Syndrome
This study is testing a special heart imaging technique called Cardiac AngioMR to see how well it can help diagnose heart and blood vessel problems in adults with Turner Syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 33 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Azienda Ospedaliero-Universitaria di Modena Academic / other |
| Locations | 1 site (Modena) |
| Trial ID | NCT06178887 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the use of noninvasive cardiac imaging, specifically Cardiac AngioMR, to diagnose and monitor cardiovascular anomalies in adult patients diagnosed with Turner Syndrome. Given the high prevalence of cardiovascular disease in this population, the study aims to evaluate not only thoracic findings but also the distal abdominal aorta and iliac arteries, which have been under-researched. The methodology involves imaging patients who meet specific inclusion criteria, including confirmed Turner Syndrome diagnosis and age over 18, who have undergone AngioMR at 1.5 T. The goal is to enhance understanding and management of cardiovascular risks in these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with a confirmed diagnosis of Turner Syndrome who have undergone Cardiac AngioMR imaging.
Not a fit: Patients who do not have Turner Syndrome or are under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic capabilities and better management of cardiovascular health in adults with Turner Syndrome.
How similar studies have performed: While there is limited data on the specific use of Cardiac AngioMR for this purpose, the study addresses a significant gap in existing research regarding cardiovascular assessment in Turner Syndrome, suggesting a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * confirmed diagnosis of Turner Syndrome * patients underwent angioMR 1.5 T * age \> 18 years
Where this trial is running
Modena
- Unit of Endocrinology of Azienda Ospedaliera-Universitaria di Modena — Modena, Italy (Recruiting)
Study contacts
- Study coordinator: Vincenzo Rochira, Prof.
- Email: vincenzo.rochira@unimore.it
- Phone: 0593961829
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.